The entity has beta of 0.0 which indicates the returns on MARKET and VanEck Vectors are completely uncorrelated. Although it is extremely important to respect VanEck Vectors Biotech
current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators
. By inspecting VanEck Vectors Biotech technical indicators
you can presently evaluate if the expected return of 0.0% will be sustainable into the future.
VanEck Vectors Biotech Relative Risk vs. Return Landscape
If you would invest 12,942
in VanEck Vectors Biotech ETF on September 18, 2018
and sell it today you would earn a total of 0.00
from holding VanEck Vectors Biotech ETF or generate 0.0%
return on investment over 30
days. VanEck Vectors Biotech ETF is generating negative expected returns assuming volatility of 0.0% on return distribution over 30 days investment horizon. In other words, 0% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
Daily Expected Return (%)
VanEck Vectors Market Risk Analysis
Sharpe Ratio = 0.0
Based on monthly moving average VanEck Vectors is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Vectors
by adding it to a well-diversified
Over the last 30 days VanEck Vectors Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions.
|Fifty Two Week Low||111.36|
|Fifty Two Week High||136.84|
Check also Trending Equities
. Please also try Premium Stories
module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.